Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardax (CDXI)
OTHER OTC:CDXI
Cardax (CDXI) Stock Price & Analysis
2 Followers
CDXI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.43 - $0.45
Previous Close$0.43
Volume108.00
Average Volume (3M)N/A
Market Cap
$1.00
Enterprise Value$3.77M
Total Cash (Recent Filing)$61.71K
Total Debt (Recent Filing)$3.83M
Price to Earnings (P/E)―
Beta-3.11
Next Earnings
May 14, 2021EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding802,516
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.80
R-Squared0.00015
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio3.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.53
Enterprise Value/Gross Profit11.00
Enterprise Value/Ebitda-1.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDXI FAQ
What was Cardax’s price range in the past 12 months?
Cardax lowest stock price was $0.43 and its highest was $0.45 in the past 12 months.
What is Cardax’s market cap?
Currently, no data Available
When is Cardax’s upcoming earnings report date?
Cardax’s upcoming earnings report date is May 14, 2021 which is 1161 days ago.
How were Cardax’s earnings last quarter?
Cardax released its earnings results on Apr 15, 2021. The company reported -$1.74 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.74.
Is Cardax overvalued?
According to Wall Street analysts Cardax’s price is currently Overvalued.
Does Cardax pay dividends?
Cardax does not currently pay dividends.
What is Cardax’s EPS estimate?
Cardax’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cardax have?
Cardax has 802,516 shares outstanding.
What happened to Cardax’s price movement after its last earnings report?
Cardax reported an EPS of -$1.74 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Cardax?
Currently, no hedge funds are holding shares in CDXI
---
Company Description
Cardax
Cardax, Inc. is a life sciences company, which engages in the development, marketing, and distribution of consumer health products. It focuses on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The firm's product platform consists of a commercially available dietary supplement, ZanthoSyn, and pharmaceutical candidates, CDX-101 and CDX-301, which are in pre-clinical development. The company was founded on February 7, 2014 and is headquartered in Honolulu, HI.
---
Technical Analysis
---